Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk... ( SEATTLE June 3 /- Due to its incr...)

Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk Selection

Date:6/3/2008

SEATTLE, June 3 /PRNewswire/ -- Due to its increasing potential as a tool in health insurance underwriting, Lifestyle-Based Analytics (LBA) continues to receive considerable attention from insurers and the media. We've probably all seen optimistic claims about the use of consumer data as a predictor in the underwriting process. In response, Milliman expert Jonathan Shreve, FSA, offers a fresh perspective on an advance in risk selection and classification through the effective use of Lifestyle-Based Analytics.

Studies and intuition tell us that lifestyle habits and characteristics are linked to disease prevalence. Through the use of consumer data, LBA utilizes lifestyle variables to enhance the risk classification system for relevant conditions. Statistics are then applied to identify correlations between lifestyle information and prevalence of various diseases. This has proven to be extremely effective in differentiating between high-cost and low-cost insurance plan members.

LBA is increasingly viewed as a high-quality advance in the art of risk selection. Within the last decade, the amount and reliability of data collected has grown dramatically. This enhanced data enables LBA researchers to identify risk pools that correlate to certain adverse conditions. It now appears likely that LBA could be used in conjunction with other risk classification tools to produce underwriting results with a meaningfully higher degree of accuracy.

As an early developer of LBA, Milliman has now completed a number of client projects involving its use. Due to a scheduling conflict for the webinar in May, Milliman will conduct an encore free educational Webinar on June 24th, at 2 PM EDT, to share the knowledge gained in the process, and to address both the potential for and limitations of LBA. The seminar will also explore meaningful underwriting applications of LBA. Highlights of the Webinar include:

-- Details of integrating LBA with tradition
'/>"/>

SOURCE Milliman
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products
2. Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection
3. Milliman Says 2008 Medical Cost for American Family of Four Exceeds $15,600
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results

Post Your Comments:

(Date:12/1/2009).... 1 The Kerlan Jobe Ort...ngeles, has agreed to pay the United States $3 mil...l kickbacks from HealthSouth Corporation, the Just...tlement resolves allegations that HealthSouth paid...ion grants, donations to the Kerlan Jobe Foundatio...

(Date:12/1/2009)...ec. 1 A decision issued today by a... Board (NLRB) has put at risk the guaranteed raise...manente RNs, social workers, and professionals in ...rs to achieve standards at Kaiser that give us sec...e our patients need," said Jeanette Cryer, License...

(Date:12/1/2009)...gests that criteria based on computed tomography (...iver metastases after chemotherapy with the drug b...ll survival, according to a study in the December ...b to cytotoxic (toxic to cells) chemotherapy is as...tage IV colorectal cancer and higher pathologic re...

(Date:12/1/2009)...NS, Dec. 1 The American...High School Student Symposium at the New Orleans M... The symposium, which encourages an interest in he...earch, is held in conjunction with the Society,s 5...the opportunity to explore research on sickle cell...

(Date:12/1/2009)...Dec. 1 The government of Mexico Ci...ter for biomedical and nanomedical research, calle...search and development will be integrated with the... Spanish speaking university in the world. The re... 2010, has been designed by the internationally-ac...

Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2 Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2 Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2 Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2 Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3 Health News:Mexico City to Build World-Class Hub for Medical Research 2

[0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations [0] Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy [0] Criteria based on CT imaging after chemotherapy may help predict survival [1] ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum [1] Mexico City to Build World-Class Hub for Medical Research

... EPS Growth of 53.3 Percent) - , , - Confirms Dou...reased 2009 Dividend by 11 Percent - , , ABBOTT... announced financial results for the first quarter... above the mid-point of Abbott,s previous first-qu...

...upply today announced that after only 20 months it...will now officially be known as Simplex Healthcare... April 15, 2009 -- Simplex Diabetic Supply today a...ur company has accomplished our initial mission of...

...BRA and Medicare considerations; people with disab...althcare coverage , Belle...rovisions in the 2009 American Recovery and Reinve...ing to Allsup , a leading provider of Social Secu...

...to represent executive board and individual union ...on on recognition of collective bargaining rights ...April 15, 2009 -- Taubman Kimelman & Soroka ,...by Local 2222 of the American Federation of Govern...

... issue of the Journal of Clinical Sleep Medicine ...ing sleep disorders in adults with a traumatic bra...ay result in the objective resolution of the sleep...sleep apnea (OSA), three months of treatment with ...

...arasites in east and west Africa carry different r...tiveness of sulfadoxine as an antimalarial drug ma...ations for the manner in which malaria control cam...ffective than working in isolation in each country...

Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009 Simplex Diabetic Supply Changes Its Name to Simplex Healthcare Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act Taubman Kimelman & Soroka Retained by AFGE Local 2222 to Advise in Organizing of New York and New Jersey Transportation Security Officers Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms Discovery of variations in resistance to sulfadoxine across Africa

(Date:12/1/2009)...Dec. 1 Reportlinker.com announces ...its catalogue: ,, Direct to Consumer (DTC) Adv...arket Outlook, Regulatory Landscape and Case Studi...rect-to-Consumer-DTC-Advertising-in-Pharmaceutical...andscape-and-Case-Studies.html ,, Summary ,...

(Date:12/1/2009)..., Dec. 1 CeloNova BioSciences, Inc...medical devices and of specialty implants, today a...r, Thomas A. Gordy, will give an opening address f...diovascular Interventions Conference in Tel Aviv, ...rest behind and focus the rich intellectual resour...

(Date:12/1/2009)... Tenn., Dec. 1 Cumberlan...today that an independently conducted study of Ace...s N-acetylcysteine, as a cost-saving treatment for...2, Number 4 of the peer-reviewed Journal of Medic...y concludes that Acetadote is a less costly treatm...

Breaking Medicine Technology:Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8 CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6 Super sleepers could help super sizers 21 9034 1 Super sleepers could help super sizers 21 9034 2 Reading the brain without poking it 9033 1 Reading the brain without poking it 9033 2 Reading the brain without poking it 9033 3 Reading the brain without poking it 9033 4 Reading the brain without poking it 9033 5 GP bodies support guidelines for use of patient records in medical research 50226 1 GP bodies support guidelines for use of patient records in medical research 50226 2

[0] Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies [0] CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices [0] Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems

...v. 7 Data from an investigational,open-label, ran...f,PROCRIT(R) (Epoetin alfa) in treating anemia in ...(CKD) were presented today at the American Society...sing groups, including the FDA-approved,three-time...d,once-every-two-weeks (Q2W) investigational regim...

...ov. 7 Spherix Incorporated,(Nasdaq: SPEX ) repor...cal,trial of its potential type 2 diabetes drug, N...India are to provide more than 300 patients spread...ow that enrollment efforts,are underway in India, ...d,on schedule as reported during the May 2008 Annu...

Other Medicine Technology:Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6 Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting Patient Recruitment Begins in India for Phase 3 Diabetes Trial

Innova 3100 Water Bath Shaker

55D Double Platform Shaker 11 x 14

Innova 5000 Muti-Tier Shaker

...up to 16 of AutoGen's tube units to prepare 96 sam...te for bacterial cultures and enzyme reactions, su... simplify your DNA extraction process by preparing...lacing our 6-hole tube units directly onto one of ...

Medicine Products:

Innova 3100 Water Bath Shaker 55D Double Platform Shaker 11 x 14 Innova 5000 Muti-Tier Shaker AutoIncubator 96

Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk...( SEATTLE June 3 /- Due to its incr...),Health